Results 131 to 140 of about 172,741 (147)
Some of the next articles are maybe not open access.

Indoleamine-pyrrole 2,3-dioxygenase might be a prognostic biomarker for patients with renal cell carcinoma.

Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 2014
To explore the role of indoleamine-pyrrole 2,3-dioxygenase (IDO), an immunomodulatory enzyme, in renal cell carcinoma (RCC).A total of 40 patients diagnosed as RCC in the Second Xiangya Hospital were included in this study. All patients received nephrectomy. The histopathological features of samples were assessed semi-quantitatively.
Fang, Yuan   +3 more
openaire   +1 more source

Indoleamine 2,3-dioxygenase (IDO) inhibitors and cancer immunotherapy

Cancer Treatment Reviews, 2022
Sarabjot Pabla   +2 more
exaly  

Identification and Characterization of a Novel Dual Inhibitor of Indoleamine 2,3-dioxygenase 1 and Tryptophan 2,3-dioxygenase

International Journal of Tryptophan Research, 2022
Akira Asai   +2 more
exaly  

Indoleamine 2,3‐dioxygenase 1 (IDO1): an up‐to‐date overview of an eclectic immunoregulatory enzyme

FEBS Journal, 2022
Ursula Grohmann   +2 more
exaly  

Localization of Indoleamine 2,3-Dioxygenase-1 and Indoleamine 2,3-Dioxygenase-2 at the Human Maternal-Fetal Interface

International Journal of Tryptophan Research, 2020
Yoshiki Kudo   +2 more
exaly  

The Role of Indoleamine 2, 3-Dioxygenase in Immune Suppression and Autoimmunity

Vaccines, 2015
Jacques Christian Mbongue   +2 more
exaly  

Studies on Tissue and Cellular Distribution of Indoleamine 2,3-Dioxygenase 2

Journal of Histochemistry and Cytochemistry, 2012
Masato Hoshi, Yasuko Yamamoto
exaly  

Indoleamine 2,3-dioxygenase-1 is protective in atherosclerosis and its metabolites provide new opportunities for drug development

Proceedings of the National Academy of Sciences of the United States of America, 2015
Alun Davies   +2 more
exaly  

Home - About - Disclaimer - Privacy